Aberrant KIF20A Expression Is Associated with Adverse Clinical Outcome and Promotes Tumor Progression in Prostate Cancer

Table 1

Clinicopathological variables and KIF20A expression in 114 prostate cancer patients.

Variables	All	KIF20A		value^#
		Low	High
Age
<70		17	35	0.67
≥70		18	44
iPSA
>10		20	29	0.04
≤10		15	50
Tumor stage
T2		20	27	0.02
T3/T4		15	52
Gleason grade
≤7		22	25	<0.01
>7		13	54
Lymph node metastasis
No		18	30	0.18
Yes		17	49
Seminal vesicle metastasis
No		21	24	<0.01
Yes		14	55

^# value was analyzed by chi-squared test; indicates with statistical significance. iPSA: initial PSA.